ROTH-STARK\2005\JAN 13G AVI-BIOPHARMA

Company

Sarepta Therapeutics, Inc.

Filed

January 27, 2005

Accession Number

0000950138-05-000046

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →